Skip to content

Intensive Dysarthria Sessions in Adults and Children With Down Syndrome

Intensive Dysarthria Sessions in Adults and Children With Down Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01684670
Enrollment
5
Registered
2012-09-13
Start date
2014-02-28
Completion date
2016-05-31
Last updated
2016-11-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Down Syndrome, Dysarthria

Brief summary

This research study is designed to investigate the feasibility and treatment effects of a behavioral speech treatment in adults and children with Down Syndrome (DS) and dysarthria. The speech sessions will provide an intensive, articulation-based intervention focused on increasing effort during speech production via use of clear speech. A single subject multiple baselines across subjects design will be employed in a total of six subjects divided into two groups of three. Changes in dependent measures will be determined by visual inspection, effect size determination, and time series analysis. The study follows accepted procedures in rehabilitation treatment and research and there are minimal foreseeable risks associated with participation.

Interventions

BEHAVIORALSpeech sessions

Subjects will be instructed to use clear speech and increased effort when speaking.

Sponsors

University of Rhode Island
CollaboratorOTHER
University of Florida
CollaboratorOTHER
University of North Carolina, Chapel Hill
CollaboratorOTHER
Duke University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults and children with Downs Syndrome and dysarthria * Ages 8 years and older * Ability to verbally communicate; follow simple commands and/or imitate others; hear speech at a conversational level; and participate in assessment and speech sessions activities

Exclusion criteria

* Additional serious medical problems which prevent meaningful participation in the study.

Design outcomes

Primary

MeasureTime frameDescription
Speech intelligibility3-6 monthsSpeech intelligibility in sentences scored by naive listeners.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026